LEAIX
Price
$13.10
Change
+$0.04 (+0.31%)
Updated
May 23 closing price
Net Assets
274.26M
VEMIX
Price
$30.15
Change
+$0.09 (+0.30%)
Updated
May 23 closing price
Net Assets
112.08B
Interact to see
Advertisement

LEAIX vs VEMIX

Header iconLEAIX vs VEMIX Comparison
Open Charts LEAIX vs VEMIXBanner chart's image
Lazard Emerging Markets Eq Advtg Instl
Price$13.10
Change+$0.04 (+0.31%)
VolumeN/A
Net Assets274.26M
Vanguard Emerging Mkts Stock Idx Instl
Price$30.15
Change+$0.09 (+0.30%)
VolumeN/A
Net Assets112.08B
LEAIX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LEAIX vs. VEMIX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEAIX is a Buy and VEMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 112B vs. LEAIX (274M). VEMIX pays higher dividends than LEAIX: VEMIX (3.12) vs LEAIX (1.46). LEAIX was incepted earlier than VEMIX: LEAIX (10 years) vs VEMIX (25 years). LEAIX (0.95) is less costly to investors than VEMIX (0.09). LEAIX is a more actively managed with annual turnover of: 68.00 vs. VEMIX (8.00). LEAIX has a lower initial minimum investment than VEMIX: LEAIX (10000) vs VEMIX (5000000). LEAIX (10.91) and VEMIX (10.45) have marching annual gain over last year. LEAIX (46.24) and VEMIX (45.51) have equivalent 5 years return.
LEAIXVEMIXLEAIX / VEMIX
Total Expense Ratio0.900.091,000%
Annual Report Gross Expense Ratio0.950.091,056%
Fund Existence10 years25 years-
Gain YTD9.8077.904124%
Front LoadN/AN/A-
Min. Initial Investment1000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets274M112B0%
Annual Yield % from dividends1.463.1247%
Returns for 1 year10.9110.45104%
Returns for 3 years28.6123.25123%
Returns for 5 years46.2445.51102%
Returns for 10 yearsN/A30.92-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSSS2.840.01
+0.35%
Research Solutions
ATR155.94-0.71
-0.45%
AptarGroup
HLLY1.97-0.01
-0.51%
Holley
APLS17.44-0.34
-1.91%
Apellis Pharmaceuticals
SXTC1.55-0.06
-3.73%
China SXT Pharmaceuticals Inc.